Stockreport

Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer [Yahoo! Finance]

Bio-Path Holdings, Inc.  (BPTH) 
Last bio-path holdings, inc. earnings: 11/14 04:20 pm Check Earnings Report
US:NASDAQ Investor Relations: biopathholdings.com
PDF The company initiated a therapeutic program to develop BP1001-A for treating obesity and related metabolic diseases . This program marks the first application of DNAbil [Read more]